Scott L Burrows - Net Worth and Insider Trading
Scott L Burrows Net Worth
The estimated net worth of Scott L Burrows is at least $4 Million dollars as of 2024-11-29. Scott L Burrows is the CFO of Spyre Therapeutics Inc and owns about 116,422 shares of Spyre Therapeutics Inc (SYRE) stock worth over $3 Million. Scott L Burrows is also the CFO of Arcutis Biotherapeutics Inc and owns about 59,115 shares of Arcutis Biotherapeutics Inc (ARQT) stock worth over $692,237. Details can be seen in Scott L Burrows's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Scott L Burrows has not made any transactions after 2024-09-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Scott L Burrows
Scott L Burrows Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Scott L Burrows owns 2 companies in total, including Arcutis Biotherapeutics Inc (ARQT) , and Spyre Therapeutics Inc (SYRE) .
Click here to see the complete history of Scott L Burrows’s form 4 insider trades.
Insider Ownership Summary of Scott L Burrows
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ARQT | Arcutis Biotherapeutics Inc | 2023-03-06 | Chief Financial Officer |
| SYRE | Spyre Therapeutics Inc | 2024-09-03 | Chief Financial Officer |
Scott L Burrows Latest Holdings Summary
Scott L Burrows currently owns a total of 2 stocks. Among these stocks, Scott L Burrows owns 116,422 shares of Spyre Therapeutics Inc (SYRE) as of September 3, 2024, with a value of $3 Million and a weighting of 82.35%. Scott L Burrows also owns 59,115 shares of Arcutis Biotherapeutics Inc (ARQT) as of March 6, 2023, with a value of $692,237 and a weighting of 17.65%.
Latest Holdings of Scott L Burrows
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SYRE | Spyre Therapeutics Inc | 2024-09-03 | 116,422 | 27.75 | 3,230,711 |
| ARQT | Arcutis Biotherapeutics Inc | 2023-03-06 | 59,115 | 11.71 | 692,237 |
Holding Weightings of Scott L Burrows
Scott L Burrows Form 4 Trading Tracker
According to the SEC Form 4 filings, Scott L Burrows has made a total of 1 transactions in Spyre Therapeutics Inc (SYRE) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Spyre Therapeutics Inc is the sale of 18,531 shares on September 3, 2024, which brought Scott L Burrows around $522,018.
According to the SEC Form 4 filings, Scott L Burrows has made a total of 4 transactions in Arcutis Biotherapeutics Inc (ARQT) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Arcutis Biotherapeutics Inc is the sale of 291 shares on March 6, 2023, which brought Scott L Burrows around $4,441.
Insider Trading History of Scott L Burrows
- 1
Scott L Burrows Trading Performance
Scott L Burrows Ownership Network
Scott L Burrows Owned Company Details
What does Arcutis Biotherapeutics Inc do?
Who are the key executives at Arcutis Biotherapeutics Inc?
Scott L Burrows is the Chief Financial Officer of Arcutis Biotherapeutics Inc. Other key executives at Arcutis Biotherapeutics Inc include See Remarks Patrick Burnett , SVP and General Counsel Masaru Matsuda , and director & President and CEO Todd Franklin Watanabe .
Arcutis Biotherapeutics Inc (ARQT) Insider Trades Summary
Over the past 18 months, Scott L Burrows made no insider transaction in Arcutis Biotherapeutics Inc (ARQT). Other recent insider transactions involving Arcutis Biotherapeutics Inc (ARQT) include a net sale of 204,518 shares made by Patrick Burnett , a net sale of 26,241 shares made by Masaru Matsuda , and a net sale of 60,000 shares made by Howard G. Welgus .
In summary, during the past 3 months, insiders sold 175,389 shares of Arcutis Biotherapeutics Inc (ARQT) in total and bought 0 shares, with a net sale of 175,389 shares. During the past 18 months, 390,095 shares of Arcutis Biotherapeutics Inc (ARQT) were sold and 102,515 shares were bought by its insiders, resulting in a net sale of 287,580 shares.
Arcutis Biotherapeutics Inc (ARQT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arcutis Biotherapeutics Inc Insider Transactions
Scott L Burrows Mailing Address
Above is the net worth, insider trading, and ownership report for Scott L Burrows. You might contact Scott L Burrows via mailing address: C/o Arcutis Biotherapeutics, Inc., 3027 Townsgate Road, Suite 300, Westlake Village Ca 91361.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
